Oncology Pharma Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

George Malesek

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	sin datos

Actualizaciones recientes de la dirección

Recent updates

CEO

George Malesek

no data

Permanencia

Mr. George Malesek serves as Interim Chief Executive Officer at Oncology Pharma Inc. (formerly known as SourcingLink.net, Inc.). He has capital markets experience having lead and participated in the financ...

Oncology Pharma Dirección

Dirección controles de criterios 0/4

Información clave

Actualizaciones recientes de la dirección

Oncology Pharma Inc. Announces Henry Smith as New Chairman to Its Scientific Advisory Board

Oncology Pharma Announces the Appointment of James Smith as New Chief Financial Officer

Recent updates

Oncology Pharma, Inc. Vetting CROs to Develop Research Plan and Indications for Recently Licensed Cancer Combination Therapy

Oncology Pharma Inc. Moves to Fund Lead Drug Formulation & IND-Enabling Studies

Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent

Oncology Pharma Extends Licensing Agreement with Nanosmart Pharmaceuticals, Inc. for Veterinary Oncology

Oncology Pharma Inc. Announces Henry Smith as New Chairman to Its Scientific Advisory Board

Oncology Pharma Renews Licensing Agreement with Ribera Solutions LLC for Its Connect2med Clinical Trials Platform

Oncology Pharma Announces the Appointment of James Smith as New Chief Financial Officer

CEO

Permanencia